PIP, DLA and AA
If this is your first visit, check out the community guide. You will have to Join us or Sign in before you can post.
Concerned about another member's safety or wellbeing? Find out how to let us know.

Hi, my name is CathC!

Replies

  • CathCCathC Member Posts: 3 Listener
    I’ve just had my pip tribunal after 14 months and have been awarded standard rate on both. Since my assessment in October 2018 my condition has deteriorated due to spinal problems and walking is agony. The MRI for this was after my assessment and because I had to wait so long for my tribunal I’m sure it wasn’t considered at my tribunal. The mobility component was based on my other illnesses which do affect my mobility but this problem is degenerative. There was no mention of my spinal problem.Shall I contact DWP to advise them or just carry on?Thanks in advance.
  • poppy123456poppy123456 Member Posts: 22,915 Disability Gamechanger
    HI and welcome,

    I'm one of the community champions here on scope and i'm here to help and advise others.

    Great news on the PIP award. They would only take into consideration what your condition was like at the time the original decision was made. This means that your worsening of condition wouldn't have been considered.

    If you report changes to DWP now, you will be sent more forms to fill in and return with all your evidence. Another face to face assessment is most likely and you could end up losing everything you've already got. A worsening of condition doesn't mean you'll score more points for a higher award.
    Proud winner of the 2019 empowering others award. This award was given for supporting disabled people and their families for the benefit advice I have given to members here on the community.
  • CathCCathC Member Posts: 3 Listener
    Thank you, that’s what I thought .
  • Ami2301Ami2301 Community Co-Production Group Posts: 7,907 Disability Gamechanger
    Welcome to the community @CathC let us know if you have any further questions :)
    Disability Gamechanger - 2019
Sign in or join us to comment.